Literature DB >> 29459438

Non-cell-autonomous function of DR6 in Schwann cell proliferation.

Alessio Colombo1, Hung-En Hsia1,2, Mengzhe Wang3, Peer-Hendrik Kuhn2, Monika S Brill3, Paolo Canevazzi4, Regina Feederle1,5,6, Carla Taveggia4, Thomas Misgeld1,3,6,7, Stefan F Lichtenthaler8,2,6.   

Abstract

Death receptor 6 (DR6) is an orphan member of the TNF receptor superfamily and controls cell death and differentiation in a cell-autonomous manner in different cell types. Here, we report an additional non-cell-autonomous function for DR6 in the peripheral nervous system (PNS). DR6-knockout (DR6 KO) mice showed precocious myelination in the PNS Using an in vitro myelination assay, we demonstrate that neuronal DR6 acts in trans on Schwann cells (SCs) and reduces SC proliferation and myelination independently of its cytoplasmic death domain. Mechanistically, DR6 was found to be cleaved in neurons by "a disintegrin and metalloprotease 10" (ADAM10), releasing the soluble DR6 ectodomain (sDR6). Notably, in the in vitro myelination assay, sDR6 was sufficient to rescue the DR6 KO phenotype. Thus, in addition to the cell-autonomous receptor function of full-length DR6, the proteolytically released sDR6 can unexpectedly also act as a paracrine signaling factor in the PNS in a non-cell-autonomous manner during SC proliferation and myelination. This new mode of DR6 signaling will be relevant in future attempts to target DR6 in disease settings.
© 2018 The Authors.

Entities:  

Keywords:  ADAM10; DR6; Schwann cell; myelin; shedding

Mesh:

Substances:

Year:  2018        PMID: 29459438      PMCID: PMC5881626          DOI: 10.15252/embj.201797390

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  The effects of alpha-secretase ADAM10 on the proteolysis of neuregulin-1.

Authors:  Christian Freese; Alistair N Garratt; Falk Fahrenholz; Kristina Endres
Journal:  FEBS J       Date:  2009-02-11       Impact factor: 5.542

2.  Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.

Authors:  Sha Mi; Xinhua Lee; Yinghui Hu; Benxiu Ji; Zhaohui Shao; Weixing Yang; Guanrong Huang; Lee Walus; Kenneth Rhodes; Bang Jian Gong; Robert H Miller; R Blake Pepinsky
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

3.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

4.  Membrane protease proteomics: Isotope-coded affinity tag MS identification of undescribed MT1-matrix metalloproteinase substrates.

Authors:  Eric M Tam; Charlotte J Morrison; Yi I Wu; M Sharon Stack; Christopher M Overall
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

5.  Beta 4 integrin and other Schwann cell markers in axonal neuropathy.

Authors:  A Quattrini; S Previtali; M L Feltri; N Canal; R Nemni; L Wrabetz
Journal:  Glia       Date:  1996-08       Impact factor: 7.452

6.  Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter.

Authors:  Baiping Wang; Li Yang; Zilai Wang; Hui Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

7.  Ex vivo imaging of motor axon dynamics in murine triangularis sterni explants.

Authors:  Martin Kerschensteiner; Miriam S Reuter; Jeff W Lichtman; Thomas Misgeld
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

8.  An essential role for ectodomain shedding in mammalian development.

Authors:  J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

9.  Constitutive α- and β-secretase cleavages of the amyloid precursor protein are partially coupled in neurons, but not in frequently used cell lines.

Authors:  Alessio Colombo; Huanhuan Wang; Peer-Hendrik Kuhn; Richard Page; Elisabeth Kremmer; Peter J Dempsey; Howard C Crawford; Stefan F Lichtenthaler
Journal:  Neurobiol Dis       Date:  2012-08-24       Impact factor: 5.996

10.  Preparation, culture, and immortalization of mouse embryonic fibroblasts.

Authors:  Jianming Xu
Journal:  Curr Protoc Mol Biol       Date:  2005-05
View more
  5 in total

Review 1.  Proteolytic ectodomain shedding of membrane proteins in mammals-hardware, concepts, and recent developments.

Authors:  Stefan F Lichtenthaler; Marius K Lemberg; Regina Fluhrer
Journal:  EMBO J       Date:  2018-07-05       Impact factor: 11.598

2.  Seizure protein 6 controls glycosylation and trafficking of kainate receptor subunits GluK2 and GluK3.

Authors:  Martina Pigoni; Hung-En Hsia; Jana Hartmann; Jasenka Rudan Njavro; Merav D Shmueli; Stephan A Müller; Gökhan Güner; Johanna Tüshaus; Peer-Hendrik Kuhn; Rohit Kumar; Pan Gao; Mai Ly Tran; Bulat Ramazanov; Birgit Blank; Agnes L Hipgrave Ederveen; Julia Von Blume; Christophe Mulle; Jenny M Gunnersen; Manfred Wuhrer; Gerhard Rammes; Marc Aurel Busche; Thomas Koeglsperger; Stefan F Lichtenthaler
Journal:  EMBO J       Date:  2020-06-22       Impact factor: 11.598

3.  NrCAM is a marker for substrate-selective activation of ADAM10 in Alzheimer's disease.

Authors:  Tobias Brummer; Stephan A Müller; Francisco Pan-Montojo; Fumiaki Yoshida; Andreas Fellgiebel; Taisuke Tomita; Kristina Endres; Stefan F Lichtenthaler
Journal:  EMBO Mol Med       Date:  2019-04       Impact factor: 12.137

Review 4.  A Structural and Functional Perspective of Death Receptor 6.

Authors:  Xiuying Ren; Zhi Lin; Wensu Yuan
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

5.  Proteolytically generated soluble Tweak Receptor Fn14 is a blood biomarker for γ-secretase activity.

Authors:  Gökhan Güner; Marlene Aßfalg; Kai Zhao; Tobias Dreyer; Shibojyoti Lahiri; Yun Lo; Bianca Ionela Slivinschi; Axel Imhof; Georg Jocher; Laura Strohm; Christian Behrends; Dieter Langosch; Holger Bronger; Christopher Nimsky; Jörg W Bartsch; Stanley R Riddell; Harald Steiner; Stefan F Lichtenthaler
Journal:  EMBO Mol Med       Date:  2022-09-07       Impact factor: 14.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.